kabutan

TOWA PHARMA, Oct-Dec (3Q) Ordinary Profit Increases by 65%, Current Fiscal Year Dividend Revised Upward by 10 yen

Thu Feb 13, 2025 3:30 pm JST Earnings

4553 TOWA PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

TOWA PHARMACEUTICAL CO.,LTD. <4553> [TSE Prime] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 26.7% from the same period last year, reaching 21.7 billion yen. The progress rate toward the full-year plan of 22.7 billion yen was 95.8%, also surpassing the five-year average of 79.3%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to significant drop 87.1% from the same period last year to 0.94 billion yen.

At the same time, the company has increased its planned annual dividend for the current fiscal year from the original plan of 60 yen to 70 yen (compared to 60 yen in the previous period).

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit increased 64.6% from the same period last year, reaching 11.4 billion yen. The operating profit margin rose from 10.2% in the same period last year to 11.5%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2022 140,405 5,352 4,639 1,984 40.3 90.2 Feb 13, 2023 J-GAAP
Apr - Dec, 2023 168,325 13,204 17,169 11,518 234.0 70.1 Feb 13, 2024 J-GAAP
Apr - Dec, 2024 193,737 18,611 21,756 14,624 297.1 95.8 Feb 13, 2025 J-GAAP
YoY +15.1% +40.9% +26.7% +27.0% +26.9%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 Prev 138,696 12,787 12,362 8,445 171.6 30 Nov 12, 2024 J-GAAP
Oct - Mar, 2024 New 138,696 12,787 12,362 8,445 171.6 40 Feb 13, 2025 J-GAAP
Revision Rate 0.0% 0.0% 0.0% 0.0% 0.0%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 262,100 23,300 22,700 15,000 304.7 60 Nov 5, 2024 J-GAAP
Mar, 2025 New 262,100 23,300 22,700 15,000 304.7 70 Feb 13, 2025 J-GAAP
Revision Rate 0.0% 0.0% 0.0% 0.0% 0.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 120,538 10,644 14,244 9,220 187.3 30 May 14, 2024 J-GAAP
Oct - Mar, 2024 Guidance 138,696 12,787 12,362 8,445 171.6 40 Feb 13, 2025 J-GAAP
YoY +15.1% +20.1% -13.2% -8.4% -8.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 208,859 5,514 5,141 2,201 44.7 60 May 15, 2023 J-GAAP
Mar, 2024 227,934 17,647 24,477 16,173 328.6 60 May 14, 2024 J-GAAP
Mar, 2025 Guidance 262,100 23,300 22,700 15,000 304.7 70 Feb 13, 2025 J-GAAP
YoY +15.0% +32.0% -7.3% -7.3% -7.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 60,929 6,201 6,936 4,565 92.8 10.2 Feb 13, 2024 J-GAAP
Jan - Mar, 2024 59,609 4,443 7,308 4,655 94.6 7.5 May 14, 2024 J-GAAP
Apr - Jun, 2024 62,566 5,672 8,593 5,495 111.6 9.1 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 60,838 4,841 1,745 1,060 21.5 8.0 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 70,333 8,098 11,418 8,069 163.9 11.5 Feb 13, 2025 J-GAAP
YoY +15.4% +30.6% +64.6% +76.8% +76.7%

Related Articles